HK1178886A1 - Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring - Google Patents
Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ringInfo
- Publication number
- HK1178886A1 HK1178886A1 HK13105592.6A HK13105592A HK1178886A1 HK 1178886 A1 HK1178886 A1 HK 1178886A1 HK 13105592 A HK13105592 A HK 13105592A HK 1178886 A1 HK1178886 A1 HK 1178886A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carboxylic acid
- acid derivatives
- heterocyclic carboxylic
- oxazolopyrimidine ring
- substituted oxazolopyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10305043 | 2010-01-14 | ||
| PCT/EP2011/050302 WO2011086080A1 (de) | 2010-01-14 | 2011-01-12 | Heterocyclische carbonsäurederivate mit einem 2,5-substituierten oxazolopyrimidinring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1178886A1 true HK1178886A1 (en) | 2013-09-19 |
Family
ID=41820700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13105592.6A HK1178886A1 (en) | 2010-01-14 | 2013-05-10 | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8846690B2 (da) |
| EP (1) | EP2523960B1 (da) |
| JP (1) | JP5841068B2 (da) |
| KR (1) | KR101759127B1 (da) |
| CN (1) | CN102834399B (da) |
| AR (1) | AR079884A1 (da) |
| AU (1) | AU2011206616B2 (da) |
| BR (1) | BR112012017447B1 (da) |
| CA (1) | CA2804128C (da) |
| DK (1) | DK2523960T3 (da) |
| ES (1) | ES2437471T3 (da) |
| HK (1) | HK1178886A1 (da) |
| IL (1) | IL220718A (da) |
| MX (1) | MX2012007836A (da) |
| MY (1) | MY156476A (da) |
| PT (1) | PT2523960E (da) |
| RU (1) | RU2559896C2 (da) |
| SG (1) | SG182474A1 (da) |
| TW (1) | TWI482623B (da) |
| UY (1) | UY33180A (da) |
| WO (1) | WO2011086080A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR079980A1 (es) | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de oxazolopirimidina sustituida en 2,5,7 |
| TWI478929B (zh) | 2010-01-13 | 2015-04-01 | Sanofi Aventis | 含２，５，７－經取代唑并嘧啶環之羧酸衍生物 |
| MX2012007837A (es) | 2010-01-14 | 2012-07-30 | Sanofi Sa | Derivados de oxazolopirimidina 2, 5 - sustituidos. |
| PL2523962T3 (pl) * | 2010-01-14 | 2014-05-30 | Sanofi Sa | Pochodne kwasu karboksylowego posiadające pierścień 2,5-podstawionej oksazolopirymidyny |
| US9309019B2 (en) | 2010-05-21 | 2016-04-12 | Adhezion Biomedical, Llc | Low dose gamma sterilization of liquid adhesives |
| US9321787B2 (en) | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3679682A (en) * | 1970-04-23 | 1972-07-25 | Fmc Corp | CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES |
| MXPA05011597A (es) * | 2003-04-30 | 2005-12-15 | Novartis Ag | Derivados de aminopropanol como moduladores del receptor 1-fosfato de esfingosina. |
| CN1791395B (zh) * | 2003-05-19 | 2012-09-26 | Irm责任有限公司 | 免疫抑制剂化合物及组合物 |
| CL2004001120A1 (es) | 2003-05-19 | 2005-04-15 | Irm Llc | Compuestos derivados de amina sustituidas con heterociclos, inmunosupresores; composicion farmaceutica; y uso para tratar enfermedades mediadas por interacciones de linfocito, tales como enfermedades autoinmunes, inflamatorias, infecciosas, cancer. |
| KR20080047410A (ko) * | 2005-08-23 | 2008-05-28 | 아이알엠 엘엘씨 | 면역억제제 화합물 및 조성물 |
| AU2006317689B2 (en) * | 2005-11-23 | 2013-07-25 | Epix Delaware, Inc. | S1P receptor modulating compounds and use thereof |
| JP5191497B2 (ja) * | 2007-03-21 | 2013-05-08 | エピックス ファーマシューティカルズ，インコーポレイテッド | Ｓ１ｐ受容体調節化合物およびその使用 |
| TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
| JP5449346B2 (ja) * | 2008-07-15 | 2014-03-19 | サノフイ | Ｅｄｇ−１受容体アゴニストとしてのオキサゾロピリミジン類 |
| AR079980A1 (es) * | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de oxazolopirimidina sustituida en 2,5,7 |
| TWI478929B (zh) * | 2010-01-13 | 2015-04-01 | Sanofi Aventis | 含２，５，７－經取代唑并嘧啶環之羧酸衍生物 |
| AR079982A1 (es) * | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5,7- sustituido., composiciones farmaceuticas y procesos para prepararlos. |
| PL2523962T3 (pl) * | 2010-01-14 | 2014-05-30 | Sanofi Sa | Pochodne kwasu karboksylowego posiadające pierścień 2,5-podstawionej oksazolopirymidyny |
| MX2012007837A (es) * | 2010-01-14 | 2012-07-30 | Sanofi Sa | Derivados de oxazolopirimidina 2, 5 - sustituidos. |
-
2011
- 2011-01-12 MY MYPI2012002623A patent/MY156476A/en unknown
- 2011-01-12 KR KR1020127021241A patent/KR101759127B1/ko active IP Right Grant
- 2011-01-12 UY UY0001033180A patent/UY33180A/es not_active Application Discontinuation
- 2011-01-12 AU AU2011206616A patent/AU2011206616B2/en not_active Ceased
- 2011-01-12 CA CA2804128A patent/CA2804128C/en not_active Expired - Fee Related
- 2011-01-12 PT PT117003392T patent/PT2523960E/pt unknown
- 2011-01-12 AR ARP110100093A patent/AR079884A1/es active IP Right Grant
- 2011-01-12 RU RU2012134548/04A patent/RU2559896C2/ru active
- 2011-01-12 CN CN201180013920.1A patent/CN102834399B/zh active Active
- 2011-01-12 SG SG2012051173A patent/SG182474A1/en unknown
- 2011-01-12 ES ES11700339.2T patent/ES2437471T3/es active Active
- 2011-01-12 US US13/521,828 patent/US8846690B2/en active Active
- 2011-01-12 BR BR112012017447-9A patent/BR112012017447B1/pt not_active IP Right Cessation
- 2011-01-12 JP JP2012548411A patent/JP5841068B2/ja active Active
- 2011-01-12 DK DK11700339.2T patent/DK2523960T3/da active
- 2011-01-12 MX MX2012007836A patent/MX2012007836A/es active IP Right Grant
- 2011-01-12 EP EP11700339.2A patent/EP2523960B1/de active Active
- 2011-01-12 TW TW100101052A patent/TWI482623B/zh not_active IP Right Cessation
- 2011-01-12 WO PCT/EP2011/050302 patent/WO2011086080A1/de active Application Filing
-
2012
- 2012-07-02 IL IL220718A patent/IL220718A/en active IP Right Grant
-
2013
- 2013-05-10 HK HK13105592.6A patent/HK1178886A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK2523960T3 (da) | 2014-01-20 |
| JP5841068B2 (ja) | 2016-01-06 |
| CN102834399A (zh) | 2012-12-19 |
| AU2011206616A1 (en) | 2012-08-02 |
| IL220718A (en) | 2015-02-26 |
| EP2523960A1 (de) | 2012-11-21 |
| UY33180A (es) | 2011-08-31 |
| BR112012017447A2 (pt) | 2016-04-19 |
| PT2523960E (pt) | 2013-12-09 |
| RU2559896C2 (ru) | 2015-08-20 |
| AU2011206616B2 (en) | 2016-06-16 |
| TWI482623B (zh) | 2015-05-01 |
| SG182474A1 (en) | 2012-08-30 |
| CA2804128A1 (en) | 2011-07-21 |
| KR101759127B1 (ko) | 2017-07-18 |
| MY156476A (en) | 2016-02-26 |
| KR20120101731A (ko) | 2012-09-14 |
| EP2523960B1 (de) | 2013-10-16 |
| US20130072502A1 (en) | 2013-03-21 |
| CA2804128C (en) | 2017-12-12 |
| BR112012017447B1 (pt) | 2019-10-29 |
| AR079884A1 (es) | 2012-02-29 |
| MX2012007836A (es) | 2012-07-30 |
| ES2437471T3 (es) | 2014-01-10 |
| US8846690B2 (en) | 2014-09-30 |
| JP2013517242A (ja) | 2013-05-16 |
| CN102834399B (zh) | 2015-04-22 |
| TW201134474A (en) | 2011-10-16 |
| WO2011086080A1 (de) | 2011-07-21 |
| RU2012134548A (ru) | 2014-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201206440B (en) | [5,6]heterocyclic compound | |
| HK1187606A1 (zh) | 取代的 -稠合含氮雜環化合物及其用途 | |
| ZA201205788B (en) | 1,2,4-triazine-4-amine derivatives | |
| IL225770A0 (en) | Heterocyclic compounds | |
| IL221442A0 (en) | Heterocyclic compound | |
| ZA201300950B (en) | Heterocyclic compound | |
| PL2521450T3 (pl) | Grzybobójcze związki heterocykliczne | |
| AP2010005364A0 (en) | Novel heterocyclic compounds. | |
| AP3589A (en) | A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes | |
| HK1198535A1 (en) | 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4] oxazin-3-amine derivatives 5-(3-)-5--5,6--2h-[1,4]-3- | |
| PL2621903T3 (pl) | Związki n-heteroarylu | |
| HK1178886A1 (en) | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring | |
| IL220707A0 (en) | 2,5,7-substituted oxazolopyrimidine derivatives | |
| HK1178885A1 (en) | Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring | |
| IL229712A (en) | The aryl sulfonamide compounds are converted into two positions 2 and 5 | |
| EP2459573A4 (en) | SUBSTITUTED 1,2-AZABORIN HETEROCYCLES | |
| HK1180314A1 (en) | Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring 257- | |
| EP2583965A4 (en) | HETEROCYCLIC RING CONNECTION | |
| HK1178888A1 (en) | Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring | |
| EP2632255A4 (en) | HETEROCYCLIC DIAZENIUM DIOLATE DERIVATIVES | |
| IL214110A0 (en) | 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds | |
| HK1178887A1 (en) | 2,5-substituted oxazolopyrimidine derivatives as edg-1 agonists edg-1 25- | |
| GB201021416D0 (en) | Novel heterocyclic compounds | |
| GB0919816D0 (en) | Heterocyclic compounds | |
| GB0919817D0 (en) | Heterocyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220108 |